IP Library Granted Patent US 7,892,198
Granted Patent B2
US 7,892,198 · App. 10/944,479 · Granted Feb 22, 2011

Device and method for treatment of surface infections with nitric oxide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,892,198
App. No.
10/944,479
Granted
Feb 22, 2011
Kind
B2
Abstract

A device for the topical delivery of nitric oxide gas to an infected area of skin includes a source of nitric oxide gas, a bathing unit, a flow control valve, and a vacuum unit. The bathing unit is adapted to surround the area of the infected skin and form a substantially air-tight seal with the skin surface. The bathing unit is also in fluidic communication with the source of nitric oxide. The flow control valve is position downstream of the source of nitric oxide and upstream of the bathing unit. The flow control valve controls the amount of nitric oxide gas that is delivered to the bathing unit. The vacuum unit is positioned downstream of the bathing unit and is used to withdraw gas from the bathing unit. Application of nitric oxide gas to the infected area of skin reduces levels of bacteria in the infected area and promotes the healing process.

Claims (17)

1. A method to promote healing of an area of the body with a lesion, the method comprising the steps of:

providing a flow-controlled source of exogenous nitric oxide-containing gas; and

delivering the exogenous nitric oxide-containing gas to the area of the body so as to topically contact and bathe the lesion with nitric oxide gas.

2. The method of claim 1 , wherein a jet of exogenous nitric oxide-containing gas is delivered to the lesion.

3. A method to promote healing of a lesion, the method comprising the steps of:

identifying the lesion on the surface of a body;

providing a flow-controlled source of exogenous nitric oxide gas;

diluting the exogenous nitric oxide gas;

delivering the exogenous nitric oxide gas to the lesion on the surface of the body, and

topically contacting the lesion with the exogenous nitric oxide gas.

4. The method of claim 3 , wherein a jet of exogenous nitric oxide gas is delivered to the lesion.

5. A method to promote healing of a lesion on a surface of a body, the method comprising the steps of:

providing a source of exogenous nitric oxide gas;

diluting the exogenous nitric oxide gas;

delivering the diluted exogenous nitric oxide gas to the lesion, and

topically contacting the lesion with the exogenous nitric oxide gas.

6. The method of claim 5 , wherein a jet of exogenous nitric oxide is delivered to the lesion.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2025
From: SENSORMEDICS CORPORATION
To: ZOLL MEDICAL CORPORATION
Reel/Frame 072869/0633 →
SECURITY INTEREST Recorded May 9, 2019
From: SENSORMEDICS CORPORATION
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 049126/0905 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2018
From: AIT THERAPEUTICS, INC.
To: ADVANCED INHALATION THERAPIES (AIT) LTD.
Reel/Frame 047562/0295 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2018
From: ADVANCED INHALATION THERAPIES (AIT) LTD.
To: AIT THERAPEUTICS, INC.
Reel/Frame 046234/0061 →
FIRST LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: SENSORMEDICS CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 045968/0865 →
SECOND LIEN SECURITY AGREEMENT Recorded Apr 18, 2018
From: SENSORMEDICS CORPORATION
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 045782/0851 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2008
From: STENZLER, ALEX
To: SENSORMEDICS CORPORATION
Reel/Frame 020538/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2008
From: MILLER, CHRISTOPHER C.
To: PULMONOX TECHNOLOGIES CORPORATION
Reel/Frame 020538/0986 →
SECURITY INTEREST Recorded Apr 7, 2006
From: THERANOX, INC.
To: VIASYS HOLDINGS INC.
Reel/Frame 017435/0358 →